These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22627902)

  • 1. A new general biomarker-based incidence estimator.
    Kassanjee R; McWalter TA; Bärnighausen T; Welte A
    Epidemiology; 2012 Sep; 23(5):721-8. PubMed ID: 22627902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statistical considerations for cross-sectional HIV incidence estimation based on recency test.
    Gao F; Bannick M
    Stat Med; 2022 Apr; 41(8):1446-1461. PubMed ID: 34984710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving Biomarker-based HIV Incidence Estimation in the Treatment Era.
    Fellows IE; Hladik W; Eaton JW; Voetsch AC; Parekh BS; Shiraishi RW
    Epidemiology; 2023 May; 34(3):353-364. PubMed ID: 36863062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the use of adjusted cross-sectional estimators of HIV incidence.
    Wang R; Lagakos SW
    J Acquir Immune Defic Syndr; 2009 Dec; 52(5):538-47. PubMed ID: 19881357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of biomarker based incidence estimators.
    McWalter TA; Welte A
    PLoS One; 2009 Oct; 4(10):e7368. PubMed ID: 19809505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixture models for calibrating the BED for HIV incidence testing.
    Mahiane SG; Fiamma A; Auvert B
    Stat Med; 2014 May; 33(10):1767-83. PubMed ID: 24834521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmented cross-sectional studies with abbreviated follow-up for estimating HIV incidence.
    Claggett B; Lagakos SW; Wang R
    Biometrics; 2012 Mar; 68(1):62-74. PubMed ID: 21668904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating the distribution of the window period for recent HIV infections: a comparison of statistical methods.
    Sweeting MJ; De Angelis D; Parry J; Suligoi B
    Stat Med; 2010 Dec; 29(30):3194-202. PubMed ID: 21170913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BED estimates of HIV incidence: resolving the differences, making things simpler.
    Hargrove J; van Schalkwyk C; Eastwood H
    PLoS One; 2012; 7(1):e29736. PubMed ID: 22235334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mean Recency Period for Estimation of HIV-1 Incidence with the BED-Capture EIA and Bio-Rad Avidity in Persons Diagnosed in the United States with Subtype B.
    Hanson DL; Song R; Masciotra S; Hernandez A; Dobbs TL; Parekh BS; Owen SM; Green TA
    PLoS One; 2016; 11(4):e0152327. PubMed ID: 27065005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double Robust Efficient Estimators of Longitudinal Treatment Effects: Comparative Performance in Simulations and a Case Study.
    Tran L; Yiannoutsos C; Wools-Kaloustian K; Siika A; van der Laan M; Petersen M
    Int J Biostat; 2019 Feb; 15(2):. PubMed ID: 30811344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new method for estimating HIV incidence from a single cross-sectional survey.
    Fellows IE; Shiraishi RW; Cherutich P; Achia T; Young PW; Kim AA
    PLoS One; 2020; 15(8):e0237221. PubMed ID: 32785257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Getting more from heterogeneous HIV-1 surveillance data in a high immigration country: estimation of incidence and undiagnosed population size using multiple biomarkers.
    Giardina F; Romero-Severson EO; Axelsson M; Svedhem V; Leitner T; Britton T; Albert J
    Int J Epidemiol; 2019 Dec; 48(6):1795-1803. PubMed ID: 31074780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An enhanced cross-sectional HIV incidence estimator that incorporates prior HIV test results.
    Bannick M; Donnell D; Hayes R; Laeyendecker O; Gao F
    Stat Med; 2024 Jul; 43(17):3125-3139. PubMed ID: 38803064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating HIV incidence in the United States from HIV/AIDS surveillance data and biomarker HIV test results.
    Karon JM; Song R; Brookmeyer R; Kaplan EH; Hall HI
    Stat Med; 2008 Oct; 27(23):4617-33. PubMed ID: 18833636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A readily available improvement over method of moments for intra-cluster correlation estimation in the context of cluster randomized trials and fitting a GEE-type marginal model for binary outcomes.
    Westgate PM
    Clin Trials; 2019 Feb; 16(1):41-51. PubMed ID: 30295512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroconverting blood donors as a resource for characterising and optimising recent infection testing algorithms for incidence estimation.
    Kassanjee R; Welte A; McWalter TA; Keating SM; Vermeulen M; Stramer SL; Busch MP
    PLoS One; 2011; 6(6):e20027. PubMed ID: 21694760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid report on estimating incidence from cross-sectional data.
    DeMonte JB; Neilan AM; Loop MS; Ciaranello AL; Hudgens MG
    Ann Epidemiol; 2021 Jan; 53():106-108.e1. PubMed ID: 32979470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarker-based HIV incidence in a community sample of men who have sex with men in Paris, France.
    Le Vu S; Velter A; Meyer L; Peytavin G; Guinard J; Pillonel J; Barin F; Semaille C
    PLoS One; 2012; 7(6):e39872. PubMed ID: 22768150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.